Our results demonstrate that Rab1B is a significant prognostic factor independent of the TNM staging system, while MMP9 is a marginally significantly independent predictor for survival of CRC patients, which is consistent with several previous studies [22, 29]. This evidence concerns the gene RAB1B and colorectal carcinoma.